Stockreport

Examining What Is Next For Arch Therapeutics [Seeking Alpha]

Arch Therapeutics, Inc.  (ARTH) 
NASDAQ:AMEX Investor Relations: ir.archtherapeutics.com
PDF Examining What Is Next For Arch Therapeutics Summary Arch now has their first FDA approval. The company expects the review process for the CE Mark to be completed this f [Read more]